相关实验视频

Updated: Jun 12, 2025

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Published on: August 23, 2022

雷米马佐拉姆减轻了脂多糖诱导的神经炎症和认知功能障碍

Leguang Zhou¹, Hongzhao Shi², Mengzhe Xiao²

¹Department of Anesthesiology, The Second Affiliated Hospital of University of South China, Hengyang, China; University of South China Hengyang Medical School Clinical Anatomy & Reproductive Medicine Application Institute, China.

Behavioural brain research

|September 25, 2024

概括

雷米马佐拉姆是一种麻醉剂,通过减少炎症和改善小鼠的认知功能来表现出神经保护作用. 它通过调节转位蛋白 (TSPO) 和将微质转移到抗炎状态来实现这一目标.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
免疫学免疫学免疫学

背景情况:

神经炎症是认知功能障碍的关键因素,包括阿尔茨海默氏症和帕金森病.
雷米马佐拉姆是一种二甲类麻醉剂,在临床前研究中显示出抗炎和神经保护作用.
它通过抗炎机制对认知功能的影响需要进一步研究.

研究的目的:

在脂聚糖 (LPS) 诱导的神经炎症模型中研究雷米马的神经保护作用.
阐明雷米马佐拉姆对认知功能障碍和神经炎症作用的潜在机制.
评估雷米扎洛拉姆对微质激活和炎症标记物的影响.

主要方法:

一个脂聚糖 (LPS) 鼠标模型被用于诱导神经炎症和认知障碍.
雷米马佐拉姆在LPS注射之前被内注射.
用莫里斯水迷宫,新物体识别和开放场测试来评估认知功能.
分析海马组织的结构变化,炎症标志物 (IL-6,IL-1β,TNF-α) 和微质激活标志物 (TSPO,IBA-1,CD16/32,CD206).

主要成果:

雷米马佐拉姆在行为测试中逆转了LPS诱导的认知缺陷.
它改善了海马体形态,减少了神经元损伤.
雷米马佐拉姆降低了海马炎症细胞因子,抑制了微质激活,促进了M2微质两极化,并增加了TSPO表达.

结论:

在LPS诱导的认知障碍的小鼠模型中,雷米马佐拉姆表现出神经保护和抗神经炎症作用.
这些效应很可能是由转位蛋白 (TSPO) 的调节介导的.
雷米马胺抑制微质激活,并促进从促炎M1转向抗炎M2微质表型的转变.

关键词:

认知功能认知功能微质细胞中的微质细胞神经炎症是一种神经炎症.雷米马佐拉姆 (Remimazolam) 是一种药物.转位蛋白是一种转位蛋白.

更多相关视频

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.